WPRIM Management System> DCMS> Gut and Liver> 2019> 13> 1

Volume: 13 Issue: 1

1. Effect of Abdominal Visceral Fat Change on the Regression of Erosive Esophagitis: A Prospective Cohort Study. Page:25—31
2. Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention. Page:16—24
3. Relationship between Telomere Maintenance and Liver Disease. Page:11—15
4. Tips for Responding to Reviewers' Comments–from an Editor's or Reviewer's Points of View. Page:7—10
5. It's Ready for Targeting Muscle in Nonalcoholic Fatty Liver in This Era of Aging. Page:5—6
6. Is EndoFLIP Useful for Predicting Clinical Outcomes after Peroral Endoscopic Myotomy in Patients with Achalasia?. Page:3—4
7. Effects of Abdominal Visceral Fat Change on Regression of Erosive Esophagitis. Page:1—2
8. Alcohol Consumption Can Reduce the Risk of Gallstone Disease: A Systematic Review with a Dose-Response Meta-Analysis of Case-Control and Cohort Studies. Page:114—131
9. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database. Page:104—113
10. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate. Page:93—103
11. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis. Page:83—92
12. Plasma Levels of K18 Fragments Do Not Correlate with Alcoholic Liver Fibrosis. Page:77—82
13. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study. Page:67—76
14. Distinction between Chronic Enteropathy Associated with the SLCO2A1 Gene and Crohn's Disease. Page:62—66
15. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Page:54—61
16. Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease. Page:48—53
17. Continuous Infusion versus Intermittent Dosing with Pantoprazole for Gastric Endoscopic Submucosal Dissection. Page:40—47
18. Assessment of Clinical Outcomes after Peroral Endoscopic Myotomy via Esophageal Distensibility Measurements with the Endoluminal Functional Lumen Imaging Probe. Page:32—39